IL-1 receptor
Transactivation by the p65 subunit of NF kappaB in response to interleukin 1 (IL 1) involves MyD88, IL 1 receptor associated kinase 1, TRAF 6, and Rac1
9
Mass Spectrometric Analysis of the Endogenous Type I Interleukin 1 (IL 1) Receptor Signaling Complex Formed after IL 1 Binding Identifies IL 1RAcP, MyD88, and IRAK 4 as the Stable Components
9
Interleukin 1 (IL 1) gene expression, synthesis, and effect of specific IL 1 receptor blockade in rabbit immune complex colitis
10
Inflammatory and hyperproliferative skin disease in mice that express elevated levels of the IL 1 receptor (type I) on epidermal keratinocytes Evidence that IL 1 inducible secondary cytokines produced by keratinocytes in vivo can cause skin disease
10
An Epstein-Barr Virus MicroRNA Blocks Interleukin-1 (IL-1) Signaling by Targeting IL-1 Receptor 1
17
Histamine enhances interleukin (IL) 1 induced IL 1 gene expression and protein synthesis via H2 receptors in peripheral blood mononuclear cells Comparison with IL 1 receptor antagonist
8
Type 1 angiotensin receptors on macrophages ameliorate IL 1 receptor–mediated kidney fibrosis
7
Signal transduction pathways activated by the IL 1 receptor family: ancient signaling machinery in mammals, insects, and plants
8
IL 1 induced murine osteoblast IL 6 production is mediated by the type 1 IL 1 receptor and is increased by 1,25 dihydroxyvitamin D3
13
IL 1 Receptor Type II Production Is Upregulated by IL 4 and IL 13, and Downregulated by IFN γ in Mouse Gingival Epithelial Cells
11
IL 1β receptor antagonist (IL 1Ra) combined with autophagy inducer (TAT Beclin1) is an effective alternative for attenuating extracellular matrix degradation in rat and human osteoarthritis chondrocytes
14
The association between hearing impairment and polymorphisms of genes encoding inflammatory mediators in Japanese aged population
9
Role of Interleukin 1 Alpha (IL 1α) and Interleukin 1 Receptor Antagonist (IL 1RA) in Pathogenesis of Juvenile Idiopathic Arthritis and Adult Onset Rheumatoid Arthritis of Iraqi Patients
7
A phase 2 randomized, double blind study of AMG 108, a fully human monoclonal antibody to IL 1R, in patients with rheumatoid arthritis
10
Altered Interleukin-1 Receptor Antagonist and Interleukin-18 mRNA Expression in Myocardial Tissues of Patients with Dilatated Cardiomyopathy
9
The effect of interleukin 1 receptor antagonist therapy on markers of inflammation in non ST elevation acute coronary syndromes : the MRC ILA Heart Study
8
Iterleukin 1 alpha is a marker of endothelial cellular senescent
6
Interleukin 1 receptor antagonist (IL 1Ra) is an acute phase protein
12
Anti-inflammatory properties of a novel peptide interleukin 1 receptor antagonist
18
Induction of tumour necrosis factor receptor expressing macrophages by interleukin 10 and macrophage colony stimulating factor in rheumatoid arthritis
13